Fidelity Reports 10.3% Stake in Roivant Sciences (~$2.1B Position)
Roivant Sciences Ltd.
Subscribe to track ROIV
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Fidelity Reports 10.3% Stake in Roivant Sciences (~$2.1B Position)
Company: Roivant Sciences Ltd. Form: SCHEDULE 13G/A | Filed: 2026/03/06 Significance: High
Insider: FMR LLC Relationship: >10% Owner (Institutional)
Holdings Update: • Security: COMMON STOCK • Shares Owned: 73,641,253 • % of Class: 10.3% • Est. Position Value: ~$2.13 Billion
Key Insight: Fidelity (FMR LLC) confirms a massive strategic position, holding over 10% of Roivant's outstanding shares, valued at approximately $2.13 billion based on current market cap.
Market Context: This filing represents a continued high-conviction holding by one of the world's largest asset managers in the $20B biotech company.
Comprehensive Analysis
SEC Filing Analysis: Roivant Sciences Ltd.
Executive Summary
- Trading Significance: High
- Key Takeaway: Fidelity (FMR LLC) reports a massive 10.3% ownership stake, cementing its status as a top institutional holder.
- Market Impact: Neutral to Bullish (Confirms long-term institutional support).
Company Information
| Field | Value |
|---|---|
| Company | Roivant Sciences Ltd. |
| CIK | 0001635088 |
| Market Cap | $20.71 Billion |
| Industry | Pharmaceutical Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | FMR LLC (Fidelity) |
| CIK | 0000315066 |
| Relationship | >10% Beneficial Owner |
| Type | Institutional Investor |
Transaction Details
| Field | Value |
|---|---|
| Form Type | SCHEDULE 13G/A |
| Event Date | 2026-02-27 |
| Security Type | COMMON STOCK |
| Shares Owned | 73,641,253 |
| Ownership % | 10.3% |
Financial Impact Assessment
Position Materiality
| Metric | Value |
|---|---|
| Total Shares Outstanding | 715,700,000 |
| Insider Shares Owned | 73,641,253 |
| % of Shares Outstanding | 10.29% |
| Estimated Position Value | ~$2.13 Billion |
| Materiality Assessment | Highly Significant |
Impact Evaluation
- Market Cap Context: For a $20.71B company, a $2.1B position represents a foundational institutional stake.
- Ownership Concentration: Fidelity controls >10% of the float, significantly reducing available supply and indicating high conviction.
- Transaction Significance: While this is an amendment (13G/A) reporting a standing position, the maintenance of a >10% stake is a critical signal of stability.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral/Bullish
- Reasoning: The filing confirms that Fidelity has not liquidated its massive position. Crossing or maintaining the 10% threshold often signals long-term commitment rather than short-term trading.
Volume & Sentiment
- Expected Volume Impact: Low (Reporting existing holdings).
- Sentiment Indicator: Bullish. Continued support from a top-tier asset manager validates the company's valuation and prospects.
Investment Insights
Positive Market Indicators
- Institutional Validation: Fidelity's 10.3% stake is a strong vote of confidence in Roivant's pipeline and management.
- Supply Constraint: With >10% of shares locked in this single institutional position, the effective float is reduced.
Key Takeaways
- FMR LLC (Fidelity) is a dominant shareholder with 10.3% ownership.
- The position is valued at over $2.1 billion, making it a critical holding for the fund.
- This 13G/A filing updates the market on the size of this stake as of Feb 27, 2026, confirming no major exit has occurred.
Additional Context
Transaction Notes
- Filing Type: Schedule 13G/A indicates this is an amendment to a previous filing, likely updating the share count or percentage ownership.
- Joint Filing: Filed on behalf of FMR LLC and Abigail P. Johnson, indicating control through the Johnson family's ownership of FMR.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
